CPCI.EGX Cairo Pharmaceuticals

613.48 EGP
Close of Oct 29, 2026
246.54 613.48
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is CPCI.EGX undervalued?

Graham number

The Graham number of Cairo Pharmaceuticals cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cairo Pharmaceuticals fundamental analysis

No fundamental analysis for Cairo Pharmaceuticals yet.

Cairo Pharmaceuticals stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.